LAVIZZO-MOUREY RISA J
LAVIZZO-MOUREY RISA J's purchase track record
LAVIZZO-MOUREY RISA J has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/25/2021 | INTC | $248K | +5.9% | -3.4% | -5.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Intel Shares Drop 3% Amid AI Chip Rotation. Intel shares fell 3% along with AMD as investors rotate out of AI‑focused chip names. The drop comes amid a broader selloff in the sector after concerns about an AI bubble. Analysts are watching Intel’s upcoming earnings to see if it can meet expectations.
Transaction History
| GEHC | ▲ Buy | Grant | 3,092 | $0 | 5/28/2025 | View on chart |
| GEHC | ▲ Buy | Grant | 2,440 | $0 | 5/21/2024 | View on chart |
| INTC | ▲ Buy | Option Exercise | 7,152 | — | 5/7/2024 | View on chart |
| GEHC | ▲ Buy | Grant | 3,584 | $0 | 5/23/2023 | View on chart |
| INTC | ▲ Buy | Option Exercise | 4,828 | — | 5/11/2023 | View on chart |
| GEHC | ▲ Buy | Grant | 1,041 | — | 1/3/2023 | View on chart |
| INTC | ▲ Buy | Option Exercise | 3,720 | — | 5/12/2022 | View on chart |
| INTC | ▲ Buy | Option Exercise | 1,993 | — | 1/30/2022 | View on chart |
| INTC | ▲ Buy | Open Market | 5,000 | $248K | 10/25/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
GEHC Secures CE Mark for MINItrace Magni Cyclotron
GE HealthCare (GEHC) has received CE approval for its MINItrace Magni cyclotron, expanding its PETtrace™ solid‑target platform to include copper‑64. The approval follows research showing its End‑tial Control software can reduce fresh gas flow in anesthesia settings. In addition, HeartBeam has joined a European consortium to develop at‑home ECG monitoring for early detection of acute coronary syndrome. These developments broaden GEHC’s product portfolio and support its investment narrative.
GEHC Secures CE Mark for MINItrace Magni Cyclotron. GE HealthCare (GEHC) has received CE approval for its MINItrace Magni cyclotron, expanding its PETtrace™ solid‑target platform to include copper‑64. The approval follows research showing its End‑tial Control software can reduce fresh gas flow in anesthesia settings. In addition, HeartBeam has joined a European consortium to develop at‑home ECG monitoring for early detection of acute coronary syndrome. These developments broaden GEHC’s product portfolio and support its investment narrative.